Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 49 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Nirogacestat for treating desmoid tumours	Nirogacestat (PF-3084014;Ogsiveo)	Desmoid Tumour	Musculoskeletal System	2024	View \| Download
Nivolumab for treating advanced clear cell renal cell carcinoma after systemic treatment	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2024	View \| Download
Odevixibat for treating biliary atresia in children following Kasai hepatoportoenterostomy	Odevixibat (A4250)	Biliary atresia	Hepatology	2024	View \| Download
Olezarsen for treating familial chylomicronaemia syndrome	Olezarsen (ISIS 678354; AKCEA-APOCIII-LRx)	Familial chylomicronaemia syndrome (FCS)	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2024	View \| Download
Pembrolizumab adjuvant for urothelial carcinoma and/or localised muscle invasive bladder cancer	Pembrolizumab (Keytruda; MK-3475)	Urothelial cancer	Urological Cancer	2024	View \| Download
Ponatinib for chronic myeloid leukaemia in paediatric patients	Ponatinib (AP24534)	Chronic myeloid leukaemia (CML)	Haematological Cancer and Lymphomas	2024	View \| Download
Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer	Endocrine therapy , Ribociclib (Kisqali; LEE-011; ribociclib succinate)	Breast cancer , Non-small-cell lung cancer (NSCLC)	Breast Cancer , Lung and Respiratory Cancer	2024	View \| Download
Sarconeos for treating severe COVID-19 in people aged 45 years and over	Sarconeos (BIO101; BIO 101; BIO-101; Ruvembri)	COVID-19	Infectious Disease	2024	View \| Download
Sasanlimab with Bacillus Calmette-Guérin for treating high-risk non-muscle invasive bladder cancer	Bacillus Calmette-Guerin (BCG; BCG Tokyo-172; OncoTICE) , Sasanlimab (PF-06801591)	Bladder cancer	Urological Cancer	2024	View \| Download
Secukinumab biosimilar for treating plaque psoriasis	Secukinumab biosimilar (BAT2306)	Plaque psoriasis	Dermatology	2024	View \| Download